evidence table

Glucosamine Knee Osteoarthritis Meta-Analysis Evidence Table

Structured evidence table for Glucosamine Knee Osteoarthritis Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Glucosamine Knee Osteoarthritis Meta-AnalysisBackground Osteoarthritis is a common joint disease, especially among individuals aged 50 and older, leading to symptoms such as pain, stiffness, and functional limitations, particularly in weight-bearing joints like the knees.2Čeh T (2026)Complementary effect of a combined exercise and dietary supplement intervention in individuals with knee osteoarthritis: study protocol for a randomized, double-blind, placebo-controlled trial.
Glucosamine Knee Osteoarthritis Meta-AnalysisKnee osteoarthritis (KOA) is increasingly prevalent, making effective treatment strategies critical.2Čeh T (2026)Complementary effect of a combined exercise and dietary supplement intervention in individuals with knee osteoarthritis: study protocol for a randomized, double-blind, placebo-controlled trial.
Glucosamine Knee Osteoarthritis Meta-Analysis, , d d N Figure Chondroitin sulfate (CS) is an anionic, sulfated glycosaminoglycan found in various connective tissues, including cartilage, bone, ligaments, tendons, and skin.3Silva Vitor Alfredo de Santana (2025)Impact of Symptomatic Slow-Acting Drugs on Inflammatory Pathways in Osteoarthritis: Therapeutic Advances and Future Challenges
Glucosamine Knee Osteoarthritis Meta-AnalysisIn terrestrial animals, it is predominantly found as monosulfated disaccharides at the 4-O or 6-O positions of GalNAc (CS-A and CS-C, respectively), along with a small percentage of nonsulfated disaccharides (CS-0).3Silva Vitor Alfredo de Santana (2025)Impact of Symptomatic Slow-Acting Drugs on Inflammatory Pathways in Osteoarthritis: Therapeutic Advances and Future Challenges
Glucosamine Knee Osteoarthritis Meta-AnalysisWhile foundational and pioneering studies are acknowledged, particular emphasis is placed on the most recent evidence to capture the current state of knowledge, clarify ongoing controversies, and highlight the latest therapeutic advances.3Silva Vitor Alfredo de Santana (2025)Impact of Symptomatic Slow-Acting Drugs on Inflammatory Pathways in Osteoarthritis: Therapeutic Advances and Future Challenges
Glucosamine Knee Osteoarthritis Meta-AnalysisOsteoarthritis (OA) is a highly prevalent musculoskeletal rheumatic disorder that significantly impacts individual health, healthcare systems, and overall socioeconomic costs.OA remains a substantial global health burden: in 2020, an estimated 595 million people (≈7.6% of the global population) had OA, representing a 132.2% increase in cases since 1990.3Silva Vitor Alfredo de Santana (2025)Impact of Symptomatic Slow-Acting Drugs on Inflammatory Pathways in Osteoarthritis: Therapeutic Advances and Future Challenges
topicGlucosamine Knee Osteoarthritis Meta-Analysis
claimBackground Osteoarthritis is a common joint disease, especially among individuals aged 50 and older, leading to symptoms such as pain, stiffness, and functional limitations, particularly in weight-bearing joints like the knees.
evidence level2
citationČeh T (2026)
sourceComplementary effect of a combined exercise and dietary supplement intervention in individuals with knee osteoarthritis: study protocol for a randomized, double-blind, placebo-controlled trial.
topicGlucosamine Knee Osteoarthritis Meta-Analysis
claimKnee osteoarthritis (KOA) is increasingly prevalent, making effective treatment strategies critical.
evidence level2
citationČeh T (2026)
sourceComplementary effect of a combined exercise and dietary supplement intervention in individuals with knee osteoarthritis: study protocol for a randomized, double-blind, placebo-controlled trial.
topicGlucosamine Knee Osteoarthritis Meta-Analysis
claim, , d d N Figure Chondroitin sulfate (CS) is an anionic, sulfated glycosaminoglycan found in various connective tissues, including cartilage, bone, ligaments, tendons, and skin.
evidence level3
citationSilva Vitor Alfredo de Santana (2025)
sourceImpact of Symptomatic Slow-Acting Drugs on Inflammatory Pathways in Osteoarthritis: Therapeutic Advances and Future Challenges
topicGlucosamine Knee Osteoarthritis Meta-Analysis
claimIn terrestrial animals, it is predominantly found as monosulfated disaccharides at the 4-O or 6-O positions of GalNAc (CS-A and CS-C, respectively), along with a small percentage of nonsulfated disaccharides (CS-0).
evidence level3
citationSilva Vitor Alfredo de Santana (2025)
sourceImpact of Symptomatic Slow-Acting Drugs on Inflammatory Pathways in Osteoarthritis: Therapeutic Advances and Future Challenges
topicGlucosamine Knee Osteoarthritis Meta-Analysis
claimWhile foundational and pioneering studies are acknowledged, particular emphasis is placed on the most recent evidence to capture the current state of knowledge, clarify ongoing controversies, and highlight the latest therapeutic advances.
evidence level3
citationSilva Vitor Alfredo de Santana (2025)
sourceImpact of Symptomatic Slow-Acting Drugs on Inflammatory Pathways in Osteoarthritis: Therapeutic Advances and Future Challenges
topicGlucosamine Knee Osteoarthritis Meta-Analysis
claimOsteoarthritis (OA) is a highly prevalent musculoskeletal rheumatic disorder that significantly impacts individual health, healthcare systems, and overall socioeconomic costs.OA remains a substantial global health burden: in 2020, an estimated 595 million people (≈7.6% of the global population) had OA, representing a 132.2% increase in cases since 1990.
evidence level3
citationSilva Vitor Alfredo de Santana (2025)
sourceImpact of Symptomatic Slow-Acting Drugs on Inflammatory Pathways in Osteoarthritis: Therapeutic Advances and Future Challenges

Learn next

Related evidence and supplement guides

SupplementBerberinePlant alkaloid with clinical evidence rivalling metformin for blood glucose control and lipid ma...GuideCurcumin Knee Osteoarthritis Meta-analysis: What the Evidence SaysCurcumin Knee Osteoarthritis Meta-analysis has 1 source documents in the current Migaku evidence...GuideGlucosamine Knee Pain Meta-analysis: What the Evidence SaysGlucosamine Knee Pain Meta-analysis has 2 source documents in the current Migaku evidence databa...GuideGlucosamine Cartilage Health Meta-analysis: What the Evidence SaysGlucosamine Cartilage Health Meta-analysis has 2 source documents in the current Migaku evidence...GuideGlucosamine Mobility Meta-analysis: What the Evidence SaysGlucosamine Mobility Meta-analysis has 2 source documents in the current Migaku evidence databas...AnswerDoes Glucosamine Cartilage Health Meta-Analysis work?Glucosamine Cartilage Health Meta-Analysis has evidence relevant to strength of evidence and wha...AnswerIs Glucosamine Cartilage Health Meta-Analysis safe?Glucosamine Cartilage Health Meta-Analysis has evidence relevant to safety, limits, and clinicia...AnswerWhat does the evidence say about Glucosamine Cartilage Health Meta-Analysis?Glucosamine Cartilage Health Meta-Analysis has evidence relevant to benefits, uncertainty, and p...

Source documents

  1. Complementary effect of a combined exercise and dietary supplement intervention in individuals with knee osteoarthritis: study protocol for a randomized, double-blind, placebo-controlled trial.
  2. Impact of Symptomatic Slow-Acting Drugs on Inflammatory Pathways in Osteoarthritis: Therapeutic Advances and Future Challenges